Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Jun 15, 2016 $36.18 $37.04 $35.54 $36.80 337 819
Jun 14, 2016 $34.97 $36.24 $34.64 $35.76 411 098
Jun 13, 2016 $34.95 $36.11 $33.70 $34.91 412 021
Jun 10, 2016 $34.00 $35.94 $33.26 $35.44 507 295
Jun 09, 2016 $35.83 $36.07 $34.15 $34.50 303 870
Jun 08, 2016 $35.84 $36.40 $35.00 $36.16 264 300
Jun 07, 2016 $36.68 $37.67 $35.66 $35.76 271 661
Jun 06, 2016 $36.24 $37.56 $35.48 $37.05 388 604
Jun 03, 2016 $36.99 $36.99 $34.89 $36.19 356 500
Jun 02, 2016 $33.76 $37.28 $33.76 $37.23 408 809
Jun 01, 2016 $34.09 $34.56 $33.36 $33.90 410 883
May 31, 2016 $34.15 $34.41 $33.50 $34.21 460 048
May 27, 2016 $34.35 $34.44 $33.29 $33.89 293 727
May 26, 2016 $34.72 $34.79 $34.16 $34.35 370 584
May 25, 2016 $34.79 $34.89 $34.01 $34.78 419 248
May 24, 2016 $34.06 $34.83 $33.51 $34.47 374 362
May 23, 2016 $33.73 $34.78 $33.53 $34.06 318 625
May 20, 2016 $33.15 $33.73 $32.74 $33.68 303 362
May 19, 2016 $32.64 $33.30 $32.07 $32.95 391 974
May 18, 2016 $31.80 $33.33 $31.80 $32.89 341 825
May 17, 2016 $32.45 $32.99 $31.81 $32.04 347 947
May 16, 2016 $29.60 $32.40 $29.41 $32.22 373 701
May 13, 2016 $28.57 $29.60 $28.35 $29.37 197 192
May 12, 2016 $29.91 $29.91 $28.00 $28.57 261 039
May 11, 2016 $31.45 $31.82 $29.68 $29.73 239 259
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT